SEIB buys Colchester-based WRS Insurance Brokers
WRS specialises in the social welfare sector and provides cover for charities, churches and care and community groups.
SEIB Insurance Brokers has bought Colchester-based WRS Insurance Brokers for an undisclosed sum.
The business stated that WRS will continue to operate from its Colchester office and under the management of its former director, Chris Chapman, following the deal.
SEIB explained it will retain all of the current staff members. WRS specialises in the social welfare sector and also provides business and property insurance.
According to the broker, WRS does business from an “ethical standpoint” and
Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.
To access these options, along with all other subscription benefits, please contact info@insuranceage.co.uk.
You are currently unable to print this content. Please contact info@insuranceage.co.uk to find out more.
You are currently unable to copy this content. Please contact info@insuranceage.co.uk to find out more.
Copyright Infopro Digital Limited. All rights reserved.
As outlined in our terms and conditions, https://www.infopro-digital.com/terms-and-conditions/subscriptions/ (point 2.4), printing is limited to a single copy.
If you would like to purchase additional rights please email info@insuranceage.co.uk
Copyright Infopro Digital Limited. All rights reserved.
You may share this content using our article tools. As outlined in our terms and conditions, https://www.infopro-digital.com/terms-and-conditions/subscriptions/ (clause 2.4), an Authorised User may only make one copy of the materials for their own personal use. You must also comply with the restrictions in clause 2.5.
If you would like to purchase additional rights please email info@insuranceage.co.uk
More on Broker
Interview: Duncan Pritchard, CEO of Commercial Express
Last year Commercial Express garnered extensive attention from the broker community with its slew of eye-catching product launches, CEO Duncan Pritchard tells Insurance Age about the growth of the business and what is coming next.
Biba 2025 Countdown: Crawford & Company’s Paul Lofkin
The Biba conference starts tomorrow and Paul Lofkin, president, UK & Ireland at Crawford & Company, explains why technology should be embedded at the heart of modern broking; tips its limited-edition tote bags to be the envy of the event; and reveals its plan to bring Cuban flair to the gathering.
Only 20% of brokers working with AI – Open GI warns of smaller broker ‘gulf’
Research from Open GI has found as many as 80% of insurance brokers have yet to implement AI into their business, with the software house warning of a “gulf” between the progress of national brokers and smaller regional firms when it comes to gaining an advantage from early AI adoption.
JMG confirms new investor
Chicago-headquartered private equity house GTCR has invested in JMG Group alongside existing backer Synova and the broker’s leadership team.
Blog: How can the industry maintain Biba fever in the new era?
Heading into another Biba conference, there will be some similarities compared to previous years, but with changes in the market through large deals, what can brokers expect as the trade body hails a new era? Rosie Simms shares her thoughts.
Biba 2025 Countdown: Iprism Underwriting’s Ian Lloyd
With just days to go until the 2025 British Insurance Brokers’ Association conference, Ian Lloyd, CEO of Iprism Underwriting reveals the MGA will be celebrating two decades in style on its stand, highlights how an onus on ‘comfort’ will mean a ‘generous collar’ on his shirts, and recommends a local Chinese restaurant for those attending the event.
Brokers closed Q1 with optimism on growth at five-year high – Aviva
Brokers’ optimism for growth reached its highest level in the past five years this March, according to Aviva’s Broker Barometer research.
Ex-Bollington boss Moors joins Broadway
Former Bollington leader Paul Moors is to become a director of Broadway Insurance Partners, subject to regulatory approval.